Brief: Aarti Drugs US FDA Conducted Inspection At Unit's Manufacturing Facility At Baddi
01/08/2024 14:37
Aug 1 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* US FDA CONDUCTED INSPECTION AT UNIT'S MANUFACTURING
FACILITY AT
BADDI
* PINNACLE IS IN RECEIPT OF ESTABLISHMENT INSPECTION REPORT
Source text for Eikon: ID:nNSEHby3R
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees